Drug Shortage Report for GALANTAMINE ER
Report ID | 114761 |
Drug Identification Number | 02443015 |
Brand name | GALANTAMINE ER |
Common or Proper name | GALANTAMINE |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | GALANTAMINE |
Strength(s) | 8MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-06-01 |
Actual start date | 2020-06-03 |
Estimated end date | 2020-12-30 |
Actual end date | 2021-02-09 |
Shortage status | Resolved |
Updated date | 2021-02-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2021-02-10 | English | Compare |
v14 | 2021-02-09 | French | Compare |
v13 | 2021-02-09 | English | Compare |
v12 | 2020-12-03 | French | Compare |
v11 | 2020-12-03 | English | Compare |
v10 | 2020-10-20 | French | Compare |
v9 | 2020-10-20 | English | Compare |
v8 | 2020-07-08 | French | Compare |
v7 | 2020-07-08 | English | Compare |
v6 | 2020-06-04 | English | Compare |
v5 | 2020-06-03 | French | Compare |
v4 | 2020-06-03 | English | Compare |
v3 | 2020-06-02 | English | Compare |
v2 | 2020-05-11 | French | Compare |
v1 | 2020-05-11 | English | Compare |
Showing 1 to 15 of 15